As shown in Figure 1, in the first year the curve of cumulative incidence of BM in EGFR mutated patients rises slower than in EGFR wild type, yet after one year the curves of EGFR mutant and EGFR wild type tumours overlap. Here, EGFR is linked to neoplasm.